feedburner

Enter your email address:

Delivered by FeedBurner

COVID-19: Favipiravir shows hope in Mumbai trial

While the WHO last week recommended that antiviral remdesivir not be
used for severely ill Covid-19 patients, Mumbai doctors published the
first scientific study showing another antiviral, favipiravir, reduced
the "cure time" in mild cases.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/covid-19-favipiravir-shows-hope-in-mumbai-trial/articleshow/79363011.cms



0 comments:

Post a Comment